ABT-116

• Description:

  ABT-116 is an orally active antagonist of transient receptor potential vanilloid type 1 (TRPV1) . ABT-116 has analgesic efficacy. ABT-116 can be used for the research of neurological disease[1].

• UNSPSC:

  12352005

• Target:

  TRP Channel

• Related Pathways:

  Membrane Transporter/Ion Channel; Neuronal Signaling

• Field of Research:

  Neurological Disease

• Smiles:

  O=C(NCC1=CC=C(C(F)(F)F)C=C1CCC(C)(C)C)NC2=CC=CC3=C2C=NN3C

• Molecular Formula:

  C23H27F3N4O

• Molecular Weight:

  432.48

• References & Citations:

  [1]Niyom S, et al. Comparison of the analgesic efficacy of oral ABT-116 administration with that of transmucosal buprenorphine administration in dogs. Am J Vet Res. 2012 Apr;73 (4) :476-81.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• Isoform:

  TRPV1

• CAS Number:

  [1008529-42-7]